Kraig Biocraft Laboratories, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.3M | $-3.1M | $-2.1M | $-1.9M | $-7.5M | $-1.6M | $-1.3M | $-1.8M |
| Depreciation & Amortization | $20.3K | $17.0K | $15.4K | $7.2K | $5.9K | $5.6K | $5.4K | — |
| Depreciation | $20.3K | $17.0K | $15.4K | $7.2K | $5.9K | $5.6K | $5.4K | $453 |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | $0 | $550.0K | $312.0K | $414.0K |
| Net Cash from Operating Activities | $-729.5K | $-1.0M | $-967.6K | $-904.6K | $-800.2K | $-562.9K | $-556.1K | $-195.5K |
| Investing Activities | ||||||||
| Capital Expenditures | $31.2K | $2.5K | $39.3K | $41.8K | $3.5K | $0 | $1.2K | $26.7K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-31.2K | $-2.5K | $-39.3K | $-41.8K | $-3.5K | $-192 | $-7.2K | $-26.7K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $480.0K | $1.1M | $750.0K | $1.1M | $1.0M | $421.5K | $666.4K | $289.9K |
| Net Change in Cash | $-280.7K | $60.7K | $-256.8K | $199.7K | $241.6K | $-141.6K | $103.2K | $67.7K |
| Free Cash Flow | $-760.7K | $-1.0M | $-1.0M | $-946.4K | $-803.6K | $-562.9K | $-557.3K | $-222.2K |